title: Screening Cuts Ovarian Cancer Mortality.
abstract: Based on a study that began in 2001, researchers have concluded that ovarian cancer screening increases survival. Disease-related mortality was 20% lower among women who received multimodal screening-annual testing of CA125 blood levels and, if CA125 was abnormal, additional CA125 tests and perhaps transvaginal ultrasound-than among those who weren't screened. When researchers factored in the delayed benefits of screening, the mortality reduction was 22%.
mesh_terms: D000368:Aged; D018394:CA-125 Antigen / Q000097:blood*; D002986:Clinical Trials as Topic; D055088:Early Detection of Cancer; D005260:Female; D006801:Humans; D008403:Mass Screening; D008565:Membrane Proteins / Q000097:blood*; D008875:Middle Aged; D010051:Ovarian Neoplasms / Q000097:blood / Q000175:diagnosis* / Q000401:mortality*; D012307:Risk Factors
chemical_list: D018394:CA-125 Antigen; C451759:MUC16 protein, human; D008565:Membrane Proteins